CoQ10 to reduce inflammation after heart surgery
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether CoQ10 (a natural nutrient) can lessen harmful inflammation and help protect organs after cardiovascular surgery. If you qualify, you may receive CoQ10 during the surgical period and be followed for how your body responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (man or woman).
- You are scheduled to have cardiovascular (heart or blood vessel) surgery.
- You agree to take part in the study and sign the consent form.
- If you are pregnant, you cannot join this study.
- If you plan to become pregnant during the study, you cannot join.
- You may need to have fewer than 2 signs of metabolic syndrome to be eligible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called a PCSK9 inhibitor can reduce harmful inflammation and organ damage in people recovering from coronary artery bypass surgery (CABG). If you are scheduled for bypass surgery within a month, this study may be an option for you.
This trial tests if taking coenzyme Q10 before and after thoracoscopic lung surgery can reduce pain. It may help you recover more comfortably.
This trial tests whether combining two natural supplements (CoQ10 and glutathione) can protect your kidneys during heart bypass surgery. It may help prevent acute kidney injury, a common complication after these procedures.
This trial tests whether taking Coenzyme Q10, a natural supplement, can improve heart health markers in people who have or are at high risk for metabolic syndrome. Metabolic syndrome is a group of conditions like high blood sugar, high blood pressure, and belly fat that raise your risk for heart disease and diabetes.
This study looks at ways to lower the chance of heart-related problems after major surgery that is not directly related to the heart. It focuses on people at higher heart risk who are expected to stay in the hospital for at least two days after surgery.
This study tests whether the drug colchicine can reduce inflammation and protect organs during and after planned heart surgery. It may help people recover better.
Hear when a new Cardiovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.